Medical Biomimetics Market to Register Significant Gains By 2025

Medical Biomimetics Market to Register Significant Gains By 2025

Medical biomimetics market has gained traction, being an innovative form of technology that uses natural imitation and nature inspired design in a bid to improve human life and facilitate with advanced medical products and procedures. According to U.S. census bureau’s 2017 national population projection, people aged more than 65 years will surpass 76.7 million mark while people under 18 years of age will be about 78 million in the U.S. by 2035.

Increased number of chronic diseases leading to organ failure and geriatric population growth are some major factors that will propel demand for biomimetic products. It has been projected that global medical biomimetics market will breach US$35 billion mark by 2025.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/767

The application segment of medical biomimetics industry is classified into tissue engineering, wound healing, drug delivery and other including nanomedicine, plastic surgery, drug discovery, medical engineering and enzymatic modification. Plastic surgery is used to repair and reconstruct missing or damaged tissue and skin. Various biomimetics applications in plastic surgery are scaffold formation, craniofacial surgery to restore facial aesthetics, function and form.

Mounting cases of injuries and accidents have resulted in the requirement for prosthetic limbs. Growing demand for implants and orthopedic prosthesis in many regions is expected to boost the need for biomimetics orthopedic. Technological advancements and innovations like the development of augmented bone graft are some of the factors expected to positively boost product demand. Reports indicate that the orthopedic product sector seized more than 30% of the market share in 2018 and is assessed to witness momentous growth during the estimated period.

Germany medical biomimetics industry overtook European region in 2018 and is expected to rise at 5.8% CAGR through 2025. Increasing geriatric population and unhealthy lifestyle prone to suffering from organ failure, rising incidence of ophthalmology, cardiovascular and orthopedic disorders are some major factors that will drive medical biomimetics adoption in Germany.

The global medical biomimetics market’s competitive hierarchy is comprised of key companies including BioHorizons IPH, Biomimetics Technologies, Avinent, Abbott, Applied Biomimetic, and Veryan Medical.

Request for customization @ https://www.decresearch.com/roc/767

Partial Chapter of the Table of Content

Chapter 4.  Medical Biomimetics Market, By Product

4.1. Key segment trends

4.2. Cardiovascular

4.2.1.  Market size, by region, 2014-2025 (USD Million)

4.3. Orthopedic

4.3.1.  Market size, by region, 2014-2025 (USD Million)

4.3.2.  Prostheses

4.3.2.1. Medical Biomimetics Market size, by region, 2014-2025 (USD Million)

4.3.3.  Exoskeleton

4.3.3.1. Market size, by region, 2014-2025 (USD Million)

4.4. Ophthalmology

4.4.1.  Market size, by region, 2014-2025 (USD Million)

4.5. Dental

4.5.1.  Market size, by region, 2014-2025 (USD Million)

4.6. Others

4.6.1.  Market size, by region, 2014-2025 (USD Million)

Chapter 5.  Medical Biomimetics Market, By Application

5.1. Key segment trends

5.2. Plastic surgery

5.2.1.  Market size, by region, 2014-2025 (USD Million)

5.3. Wound healing

5.3.1.  Market size, by region, 2014-2025 (USD Million)

5.4. Tissue engineering

5.4.1.  Market size, by region, 2014-2025 (USD Million)

5.5. Drug delivery

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/medical-biomimetics-market